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The piriform cortex (PC) is richly innervated by corticotropin-releasing factor (CRF)
and serotonin (5-HT) containing axons arising from central amygdala and Raphe
nucleus. CRFR1 and 5-HT2A/2CRs have been shown to interact in manner where
CRFR activation subsequently potentiates the activity of 5-HT2A/2CRs. The purpose
of this study was to determine how the activation of CRFR1 and/or 5-HT2Rs
modulates PC activity at both the circuit and cellular level. Voltage sensitive dye
imaging showed that CRF acting through CRFR1 dampened activation of the Layer
II of PC and interneurons of endopiriform nucleus. Application of the selective 5-
HT2A/CR agonist 2,5-dimethoxy-4-iodoamphetamine (DOI) following CRFR1 activation
potentiated this effect. Blocking the interaction between CRFR1 and 5-HT2R with
a Tat-CRFR1-CT peptide abolished this potentiation. Application of forskolin did not
mimic CRFR1 activity but instead blocked it, while a protein kinase A antagonist
had no effect. However, activation and antagonism of protein kinase C (PKC) either
mimicked or blocked CRF modulation, respectively. DOI had no effect when applied
alone indicating that the prior activation of CRFR1 receptors was critical for DOI to
show significant effects similar to CRF. Patch clamp recordings showed that both
CRF and DOI reduced the synaptic responsiveness of Layer II pyramidal neurons.
CRF had highly variable effects on interneurons within Layer III, both increasing and
decreasing their excitability, but DOI had no effect on the excitability of this group
of neurons. These data show that CRF and 5-HT, acting through both CRFR1
and 5-HT2A/CRs, reduce the activation of the PC. This modulation may be an
important blunting mechanism of stressor behaviors mediated through the olfactory
cortex.
Keywords: piriform cortex, corticotropin-releasing factor, 5-hydroxytryptamine receptors, corticotropin
releasing factor 1 receptor, dimethoxy-4-iodoamphetamine, adapting high frequency, adapting low frequency,
non-adapting very high frequency
Abbreviations: AHF, adapting high frequency; ALF, adapting low frequency; CRF, corticotrophin-releasing factor; CRFR1,
corticotrophin-releasing factor receptor 1; DOI, dimethoxy-4-iodoamphetamine; 5-HT2A/CR, 5-hydroxytrytamine 2A/C
receptor; NavHF, non-adapting very high frequency; PC, piriform cortex.
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Introduction
In the central nervous system, CRF binds with high aﬃnity
to CRF1 receptors (CRFR1) but with only moderate aﬃnity
to CRFR2 (Zorrilla et al., 2014). CRF within CNS originates
from cell bodies in central amygdala as well as interneurons in
the cortex (Anisman et al., 2007). CRFR1 receptor activation
has been shown to have a number of diﬀering eﬀects on
cellular behavior that varies with brain region. In prefrontal
cortex it prolongs the serotonin (5-HT) induced increase in
GABAergic synaptic activity (Tan et al., 2004). While in CA1
pyramidal neurons it modulates potassium currents (A and
delayed rectiﬁer types; Kratzer et al., 2013). It may also dampen
excitability by inhibiting NMDA-induced currents in cultured
hippocampal neurons (Sheng et al., 2008). In the amygdala CRF
activates a Kv3 type potassium channels that contribute to action
potential repolarization therefore slowing ﬁring frequency (Fu
and Neugebauer, 2008). Thus the eﬀects of CRF seem to be highly
diverse. This varied functionality may arise from heterogeneity of
G proteins that couple to CRF receptors. For example, in above
mentioned studies these actions were mediated by either protein
kinase A (PKA; Fu and Neugebauer, 2008) or protein kinase C
(PKC; Tan et al., 2004) signaling pathways.
A similar situation is apparent for the neurotransmitter 5-HT
which arise from cells located in the Raphae nucleus (Sheldon
and Aghajanian, 1990). Its activity throughout the brain is highly
diverse. For example, Aghajanian and co-workers found that 5-
HT is excitatory on interneurons and inhibitory on pyramidal
cells of PC (Sheldon and Aghajanian, 1990, 1991; Marek and
Aghajanian, 1996). However, unlike CRF, this diversity in activity
of 5-HT seems to be due to the wide range of 5-HT receptor
subtypes that are heterogeneously expressed throughout the
brain.
The heterogeneous functions of both these neurotransmitters
are thought to be important in mediating stressor or anxiety
responses (Eison, 1990; Hayley et al., 2005). For example, it
has been well-documented that DOI, a 5-HT2A/CR agonist
produces very strong anxiety responses, and increases in
extrahypothalamic CRF has been associated with anxiety
disorders (Anisman et al., 2008; Magalhaes et al., 2010). CRFR1
activation can enhance 5-HT2A/CR mediated signaling via a
mechanism involving the recruitment of endosomal 5-HT2A/CR
to the plasma membrane (Magalhaes et al., 2010). Furthermore
the same study showed that prior dosing of mice with a
CRFR1 agonist enhanced DOI-induced anxiety. However, an
understanding of how these neurotransmitters aﬀect the neural
circuit behavior is incomplete and more research is needed
to understand the impact of their activation on local circuit
behavior.
One region of the brain that highly expresses both CRFR1
and 5-HT2Rs is the PC (Pazos et al., 1985; Van et al., 2000). The
PC is of interest in epilepsy because its circuitry easily supports
seizures (Ekstrand et al., 2001). We have recently shown that
PC excitability is under the control of feed forward disinhibitory
circuit that potentiates excitatory input from the lateral olfactory
tract (LOT; Birjandian et al., 2013). How CRF and/or 5-HT may
modulate this circuit is not known. Therefore, the purpose of this
study was to understand how CRFR1 activation and their possible
interaction of 5-HT2A/CR modulate the activity of the PC.
Materials and Methods
All the procedures performed for this project were in accordance
with the guidelines of Canadian council of animal care and
approved by The University of Western Ontario council on
animal care.
Slice Preparation and Dye Loading
Adult male Sprague-Dawley rats weighing 150–180 g were used
in all experiments. They were housed individually with free
access to food and water under a continuous 12 h light/dark
cycle. Animals were anesthetized with ketamine–medetomidine
hydrochloride combination and then perfused through heart
with an ice-cold artiﬁcial cerebrospinal ﬂuid (ACSF) in which
sodium ions was replaced by choline ions. The composition
of this ACSF used is choline chloride, 110 mM; KCl, 2.5 mM;
NaH2PO4, 1.2 mM; NaHCO3, 25 mM; CaCl2, 0.5 mM; MgCl2,
7 mM; sodium pyruvate, 2.4 mM; ascorbate, 1.3 mM; dextrose,
20 mM (McIntyre et al., 2002). The brains were perfused to ﬂush
any blood out of the vessels to prevent the iron in the blood from
oxidizing and causing damage to neuronal cells. The brain was
rapidly removed following perfusion and the region containing
anterior PC was carefully cut into a block to facilitate slicing by a
Vibratome (slices were 400 μM thick). The slices were incubated
at room 37◦C for 30 min and subsequently moved to room
temperature (22◦C) bath for 45 min. The perfusion, slicing and
incubation procedures were carried out in choline-ACSF with
continuous supply of carbogen (95% O2 and 5% CO2 mixture).
These slices were used for both voltage sensitive dye imaging
(VSDI) and patch clamp recording. For the VSDI slices were
incubated in the voltage sensitive dye Di-4-ANEPPS (D-199,
Invitrogen Molecular Probes, Inc., Eugene, OR, USA) for 35 min.
The stock solution of the dye was dissolved in ethanol (22mg/ml).
On the day of experiment the dye incubation was prepared by
mixing 60μl of dye stock with 500μl of fetal bovine serum (FBS),
500 μl of ACSF and 310 μl of 10% cremophore-EL solution.
The concentration of dye in the ﬁnal solution was 0.1 mg/ml.
After incubation slices were washed for 8–10 min with ACSF
and transferred to recording chamber. The temperature of the
bath was maintained at 32◦C during recordings and continuously
supplied with carbogen bubbled ACSF having a composition of
NaCl, 110 mM; KCl, 2.5 mM; NaH2PO4, 1.2 mM; NaHCO3,
25 mM; CaCl2, 2.0 mM; MgCl2, 2.0 mM; dextrose, 20 mM. The
pH and osmolarity of the solutions were adjusted to 7.3–7.4 and
297–305 mOsm respectively.
A platinum/iridium electrode (Microprobes, Inc.,
Gaithersburg, MD, USA) with a tip diameter of 200–300 μMwas
used to stimulate LOT of PC. The stimulation of each slice was in
the range of 160–200 μA, each square pulse was 2.0 ms in length.
The electrode was connected to a stimulator (S88X dual output
square pulse stimulator, Grass Technologies, Astro-Med, Inc.,
Brossard, QC, Canada), which controlled the pulse frequency
and train duration (Birjandian et al., 2013).
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Voltage Sensitive Dye Imaging
Each optical recording was about 10 s in length and consisted of
two phases. The ﬁrst contained recording of background activity
for 2 s followed by the application of stimulus for 1 s with a train
of frequencies ranging from 5 to 80 Hz. The acquisition rate was
set at 5 ms/frame. The camera saturation was set around 50% for
each recording. Optical signals were recorded by a CMOS camera
(Micam Ultima Brain Vision, Inc., Tokyo, Japan) mounted on
top of an upright microscope (Fixed stage upright microscope,
BX51WI, Olympus). The light from a 100 W halogen lamp
source (HLX 64625, Microlites Scientiﬁc, Corp.) passed through
an excitation ﬁlter (λ = 530 ± 10 nm). A long pass emission
ﬁlter (λ > 590 nm) collected the ﬂuorescent signals. A long
working distance objective was used in the experiments (XLFluor
4X N.A.0.28, Olympus). The movies were analyzed using Brain
Vision Analyzer (Tokyo, Japan) software. A detailed explanation
of the technique is described elsewhere (Birjandian et al., 2013).
Patch Clamp Electrophysiology
Patch clamp recordings were done as previously described in
McIntyre et al. (2002) and Gavrilovici et al. (2012). Patch
electrodes were pulled from borosilicate glass capillaries and ﬁlled
with K+-gluconate solution having a composition (in mM) of:
potassium gluconate 147, KCl 1, CaCl2 2, HEPES 10, EGTA 10,
Glucose 10, MgATP 2, GTP 0.3 (300 mOsm, pH 7.3–7.4).Whole-
cell patch clamp recordings were made with an Axon instruments
Patch 700B ampliﬁer (Molecular Devices, Sunnyvale, CA, USA)
from neurons in Layers II and III of anterior PC. Series resistance
compensation was performed in all recordings. The initial access
resistance was <20 M and compensated by 50–70%. Bridge
balance was set to auto to correct the voltage drop across the
membrane. All experiments were performed at 32◦C. Stimulation
of the LOT for these recordings was done in an identical manner
as that used for VSDI. Excitability of the cells was assayed
by current-clamp protocols (Axon instruments; Clampex 10.3;
500 ms pulses in 50 pA increments). For recordings done in
Layer III we have previously identiﬁed by the cluster analysis ﬁve
diﬀering functional phenotypes (Gavrilovici et al., 2012). These
clusters were named according to the terminology described by
Kroner et al. (2007) and Ascoli et al. (2008). To decide whether
interneuron signiﬁcantly slowed action potential generation
(adapted) an interspike interval ratio (IIR) was calculated. The IIR
is the ratio between the last spike interval at the end of the 500 ms
current pulse divided by the ﬁrst spike interval. An IIR < 1.25
were termed as non-adapting cells while neurons with IIR > 1.25
were classiﬁed as adapting cells. As well cells were classiﬁed based
on their ﬁring frequency (FF) at 2X current threshold (I2t). Cells
that had an average FF > 50 Hz were classiﬁed as high frequency
(HF) while those FF < 50 Hz were termed as low frequency (LF).
Cells with a FF of >100 Hz were classiﬁed as very high frequency
(vHF).
Tat Peptide Co-immunoprecipitation
Human embryonic kidney (HEK293) cells were maintained
in Eagle’s minimal essential medium with 10% FBS. HEK293
cells were seeded onto 10 cm dishes 24 h before transfection to
attain 70–80% conﬂuency. Transient transfection was performed
using a modiﬁed calcium phosphate protocol described by
Ferguson and Caron (2004). Cells were transfected with 1 μg
of YFP-SAP97 and 1 μg of either FLAG-5-HT2AR or HA-
CRFR1. These constructs have been described previously
(Dunn et al., 2013, 2014). 18 h post-transfection, cells
were washed with phosphate-buﬀered saline (PBS) and re-
suspended with trypsin containing 0.25% EDTA. 24 h after
the removal of transfection reagents, cells were treated with
Tat-Scrambled or Tat-CRFR1-CT for 2 h at the described
concentrations (Tao et al., 2008). Cells were subsequently
lysed in lysis buﬀer (50 mM Tris, pH 8.0, 150 mM NaCl,
and 1% Triton X-100) containing protease inhibitors (1 mM
AEBSF, 10 μg/ml leupeptin, and 5 μg/ml aprotinin) for 20 min
on a rocking platform at 4◦C. Samples were collected into
1.5-ml Eppendorf tubes and centrifuged at 15,000 × g for
15 min at 4◦C to pellet insoluble material. A Bronsted–Lowry
protein assay was performed, and 400 μg of protein from
each condition was incubated for 1–2 h at 4◦C with either
FLAG-immunoprecipitation beads from Sigma-Aldrich or
protein G-sepharose and mouse anti-HA antibody (1:50). After
incubation, beads were washed three times with cold lysis buﬀer
and incubated overnight at room temperature in 3x SDS Loading
Buﬀer containing 2-mercaptoethanol. Samples were separated
by SDS-PAGE, transferred to a nitrocellulose membrane,
and immunoblotted to identify co-immunoprecipitated
YFP-SAP97 (rabbit anti-GFP, 1:1000) with either FLAG-
5-HT2AR or HA-CRFR1 in the presence or absence of
Tat-CRFR1-CT.
Reagents
2,5-Dimethoxy-4-iodoamphetamine, H-89, Forskolin and BIS
were obtained from Sigma-Aldrich Co., St. Louis, MO,
USA. CRF, antisauvagine-30 and antalarmin were obtained
from Tocris Biosciences, Ellisville, MO, USA. Tat-CRFR1-CT
peptide was obtained from CanPeptide, Inc., Pointe-claire, QC,
Canada. The Tat-CRFR1-CT sequence used was YGRKKRRQRR-
PTRVSFHSIKQSTAV. This peptide has been shown previously
to prevent the functional synergism between CRFR1 and 5-
HT2Rs (Magalhaes et al., 2010). Di-4-ANEPPS stock solution was
prepared in alcohol and cremophore-EL solution which can be
stored at 4◦C for 2 months. FBS and ACSF were added on the
day of experiment. CRF stock was dissolved in HBSS and milli-Q
water mixture. DOI was prepared in alcohol and Milli-Q water.
Forskolin, H-89, BIS, antalarmin, antisauvagine-30, and PMA
stock solutions were prepared in dimethyl sulfoxide (DMSO).
All the stock solutions were made 1000 times more concentrated
than working concentrations.
Statistical Analysis
Comparison of all measured values was done using two-way
analysis of variance (ANOVA) or repeated measures ANOVA as
appropriate. Post hoc comparisons were carried out using a Fisher
Exact Test. A Mann–Whitney test (non-parametric) was used to
evaluate the action potential number data taken form pyramidal
cell recordings. The signiﬁcance for all tests was set at p < 0.05.
All statistical evaluations were done using Statview Software.
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Results
We have recently demonstrated that the activation of the PC
through the stimulation of the LOT induces a novel feed forward
disinhibitory loop that potentiates activation of the Layer II
pyramidal cell layer (see Birjandian et al., 2013) for a complete
description). Responses were followed by VSDI of the PC brain
slices (sampling rate is 200 frames/second) that include all three
layers along with the underlying dorsal endopiriform nucleus
(DEn). When the (LOT) was stimulated with a bipolar electrode
with frequencies ranging from 20 to 80 Hz for 1 s Layer II
was ﬁrst activated. This initial response was followed about 40–
50 ms later by the activation of the dorsal endopiriform nucleus
(DEn) and then (after about 200 ms) the deactivation of Layer
III. An example of a response is shown in Figure 1. The ﬁrst
frame, before the stimulation, shows of the PC Layers I–III
and endopiriform nucleus (DEn). Each subsequent frame in the
picture has a time diﬀerence of 2 s from the preceding frame.
The excitatory responses originating from Layer II and DEn are
shown in Figures 1B,D. The inhibitory response originating from
Layer III is shown in Figure 1C. The change in ﬂuorescence in
these recordings is color coded by the software so that excitation
is shown by green, yellow, and red while decreased activity is
shown by blue and magenta colors. Our interpretation of this
sequence of events is that the initial activation of the Layer II
activates inhibitory neurons in the DEn that then in turn inhibit
Layer III neurons. This disinhibition of Layer III potentiates the
activation of Layer II neurons (again see Birjandian et al., 2013)
for complete characterization of this response). In Figures 1B–D
we show the relationship between frequency of stimulation and
change in the magnitude of the response in Layers II, III, and
DEn respectively showing that the (de)activation occurs over the
gamma frequency band of stimulation trains.
CRF Reduces the Activity of the PC
We wanted to investigate how CRF might modulate this
response. This was done by comparing control input/output
relationship (as shown in Figures 1B–D) to those obtained after
ACSF containing 100 nM CRF was perfused over the slice. In
Figure 2A, the left panel shows the control response (2 s after
the stimulation) to an 80 Hz train. The middle panel shows the
equivalent response after 15–20 min of 100 nM CRF application
and the right most panel shows the response after CRF washout.
CRF reduced the activity of pyramidal cell layer as evidenced by
decreased signal (less red) in Layer II [F(1,9) = 6.58, p < 0.001,
n = 9]. Similarly, the activity of neurons in DEn was also reduced
which can be seen by decreased green/yellow/red scaling of the
ﬂuorescence signal. The decreased blue/violet color in Layer III
represents decreased disinhibitory drive arising from the DEn
neurons. In Figures 2B–D, we show the eﬀect of CRF over
the entire input/output relationships in the three areas tested.
CRF reduced the activity of Layer II pyramidal cells and the
FIGURE 1 | Activation of PC involves three kinds of responses
originating in different anatomical regions. (A) Show a 10 s long
recording where a 80 Hz stimulation was used (red, green, yellow
represents depolarization: blue, magenta, violet represent
hyperpolarization). Waves on the right side indicated by arrows
represent depolarization responses from Layer II and dorsal endopiriform
nucleus (DEn) and a hyperpolarizing response from Layer III (arrows in
the first panel represent the orientation of the slice. D: dorsal; V:
ventral; M: medial; L: lateral). (B–D) Graphs of normalized change in
F/F vs. stimulus intensity from nine recordings in the Layers II, III
and DEn respectively. Activation of each response increased over the
range of stimulation of 20–80 Hz (γ-range).
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FIGURE 2 | Activation of CRFR1 in PC reduced the activation of
pyramidal cell layer (Layer II) and dorsal endopiriform nucleus (DEn) but
attenuated the deactivation of interneuronal layer (Layer III).
Representative images taken 1 s after the end of stimulation are shown in (A)
before (left) and after the application of 100 nM CRF (middle 15 min) and after
20 min wash (right). In (B–D) we show quantification of CRFR1 effects over the
range of stimulation frequencies used to activate the circuit. CRF was most
effective on the 60 and 80 Hz stimulations. ∗p < 0.05.
cells in DEn as the curves shifted downward (Figures 2B,D).
Application of CRF also reduced the inhibition of Layer III, thus
shifting the curve upward. This CRF eﬀect was reversible within
10 min (Figure 2C). We also found that the eﬀects of CRF were
most robust within γ-frequency range (40–80 Hz). There was no
signiﬁcant diﬀerence in ﬂuorescence signals within θ to high β
frequency range (5–20 Hz).
CRFR1 Mediate the Actions of CRF in PC
Corticotropin-releasing factor exerts its actions through two
major kinds of receptor subtypes named CRFR1 and CRFR2
(Zorrilla et al., 2014). These two receptors are widely distributed
in the rat central nervous system (De Souza et al., 1985; Primus
et al., 1997; Van et al., 2000). Since these receptors bind to
diﬀerent G proteins, activate various signaling cascades and
produce diﬀerent eﬀects it is essential to understand which CRFR
subtype mediate the actions of CRF in this context. We employed
antalarmin, a CRFR1 antagonist to see if it blocks the actions of
CRF. We found that antalarmin at a concentration of 10 μM
abolished the activity of CRF [100 nM; F(1,6)= 6.542, p < 0.001,
n = 10]. In Figure 3A we show that there is no diﬀerence in
control (left panel) and CRF and antalarmin treated slice (right
panel). In Figure 3B, we show the dose/inhibition curve of
antalarmin in the presence of 100 nM CRF. We found that the
IC50 of antalarmin was 100 nM. We also tested antisuvagine-30,
a CRFR2 antagonist to determine whether CRFR2 has any role
in the actions of CRF. Antisauvagine-30 was not able to block
the actions of CRF (data not shown). These data indicate that
CRF reduces the excitability of the PC through the activation of
CRFR1.
Induction of DOI Activity is Dependent on
Previous CRF Activation of CRFR1
It has been previously reported that CRFR1 potentiates 5-HT2R
mediated signaling in vitro (Magalhaes et al., 2010). Therefore,
we wished to see if these receptors could alter PC activation
and perhaps act in similar synergistic manner. We used the
relatively selective 5-HT2A/C receptor agonist DOI. Surprisingly,
DOI had no eﬀect on the PC circuit activation (n = 5). Figure 4A
shows images of the signal distribution (1 s after the end of
1 s 60 Hz stimulus) before and after the application of DOI.
The quantiﬁcation of these results shows that no frequency
of stimulation altered circuit activity in all three layers of PC
(Figures 4B–D). To test if prior CRFR1 activation could induce
a DOI response we ﬁrst applied CRF and then DOI. Under these
conditions DOI produced similar responses to those produced by
CRF. In Figure 5 we show images of responses taken before and
after the application of these agonists. In Figure 5A the control
response is in the left panel while in the middle panel we show the
activity of CRF and in the right panel we show the eﬀect of DOI.
It is evident that DOI further reduced the eﬀects of the activation
of this circuit [F(1,9) = 9.82, p < 0.01, n = 9]. In Figure 5B we
show the quantitation of the eﬀects of CRF and DOI after CRF
in all three layer of PC. These data show that 5-HT2A/CR activity
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FIGURE 3 | The effects of CRF are blocked by the CRFR1
antagonist antalarmin. In (A) we show a representative image of the
control recording (on the left). The image on the right shows that in
presence of 10 μM antalarmin CRF was without effect on the
activation of the PC circuitry. In (B) we show dose inhibition curve for
CRFR1 receptor blockade in Layer II of PC over the range of
antalarmin concentrations used. The IC50 for antalarmin was found to
be 100 nM.
FIGURE 4 | Activation of serotonin (5-HT) receptors alone had no effect on PC circuitry. Representative images in (A) were taken before and after
application of DOI, a 5-HT2A/2CR agonist. In (B–D) we show that DOI was without effect in each region followed over the entire range of stimulation frequencies
used to activate the circuit.
is dependent on the prior activation of CRFR1. Unlike CRF, the
eﬀects of DOI were not reversible within 30 min of “washouts”
that were attempted in these experiments.
The Activity of DOI is Dependent on CRF and
5-HT2 Receptor Complex Formation Mediated
by a PDZ Domain-Containing Protein
It has been previously reported that the activation and subsequent
desensitization of CRFR1 leads to a complex formation by
CRFR1 with 5-HT2R on endosomes involved in traﬃcking to the
cell membrane (Magalhaes et al., 2010). Therefore we wanted
to determine if the DOI eﬀect after CRFR1 stimulation may
occur through the crosstalk of CRFR1 and 5-HT2A/CR, which
has previously been demonstrated to involve PDZ interactions
(Magalhaes et al., 2010). To do this, we utilized a Tat-tagged
peptide corresponding to the ﬁnal 15 amino acids of the CRFR1
carboxyl terminus (Tat-CRFR1-CT) which includes a class I
PDZ-binding motif similar to that found in 5-HT2A/CR. This
peptide was previously demonstrated to abolish the functional
crosstalk between CRFR1 and 5-HT2A/CR (Magalhaes et al.,
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FIGURE 5 | Activation of CRFR1 before the application of DOI
potentiated the CRF effects. Representative images in (A) show control (left),
after the application of CRF (middle) and the subsequent application of DOI
following CRF (right). The image on right was taken after 15 min of perfusion
with CRF. In (B–D) we show quantitation of CRFR1 and 5-HT2A/CR activation
over the range of stimulation frequencies used to activate the circuit.
∗#p < 0.01. ∗CRF effect is significantly different compared to control. # DOI
following CRF effect is significantly different from CRF. DOI was immediately
applied after the CRF application was stopped. However, there was at least
15–17 min time lapse between when the DOI application was started and the
slice was stimulated for the recording. The perfusion bath emptying rate was
maintained at 1 ml per min. When DOI was added in the absence of CRF.
2010). Therefore, we investigated whether this peptide could
sequester PDZ domain-containing proteins capable of interacting
with class I PDZ-binding motifs, thereby preventing their
interaction with CRFR1 and 5-HT2A/CRs. Figure 6 shows that
30 μM of Tat-CRFR1-CT was suﬃcient to block the interaction
of HA-CRFR1 with PDZ domain-containing protein YFP-SAP97
in HEK293 cells. Additionally, the interaction of FLAG-5-HT2AR
with PDZ domain-containing proteins was inhibited at 30 μM
of Tat-CRFR1-CT, as evidenced by a lack of interaction between
FLAG-5-HT2AR and YFP-SAP97 (Figures 6A,B). Therefore, Tat-
CRFR1-CT is capable of blocking the interaction of both CRFR1
and 5-HT2ARs with PDZ domain-containing proteins, thereby
providing a potential mechanism for the inhibition of receptor
crosstalk. Next we determined if the same peptide could prevent
the activity of DOI after CRF in brain slices. As a control we
also used a scrambled Tat-tagged sequence. The Tat-CRFR1-
CT peptide was incubated with the slices for 40 min before
the application of CRF and DOI following CRF. CRF produced
eﬀects comparable to the eﬀects that it produced in the absence
of Tat-CRFR1-CT while the DOI activity after CRF receptor
activation was abolished (Figure 7). The scrambled peptide was
without eﬀect and DOI was able to further potentiate the activity
of CRF. These observations are consistent with interpretation
that in order for DOI to have an eﬀect CRFR1 must interact with
5-HT2Rs through a complex involving PDZ domain-containing
proteins.
The Effects of CRF are Mediated through a
Protein Kinase C Dependent Signaling
Cascade
We found that CRFR1 mediates the actions of CRF as antalarmin
blocked the actions of CRF. Next we determined which signaling
cascade is activated by CRFR1 stimulation. Although the CRFR1
is usually classiﬁed as GPCR that is coupled to Gαs (activation
of adenylcyclase), there are several reports that CRFR1 signaling
can activate Gαq/11 cascades as well (Elliott-Hunt et al., 2002;
Blank et al., 2003; Wietfeld et al., 2004). To see if a Gαs mediated
pathway may be activated by CRFR1 simulation we ﬁrst used
the adenylylcyclase activator forskolin (20 μM, for 15–20 min)
to see if it would mimic the eﬀects of CRF in all layers of PC.
It did not produce eﬀects like CRF (not shown). However, the
subsequent application of CRF and/or DOI also had no eﬀect and
so activation of adenylcyclase occludes the eﬀects of CRF/DOI
(Figure 8A). Next we used the PKA antagonist H-89 (10 μM) to
see if it could aﬀect the CRF/DOI responses. It had no activity on
either the CRF or the DOI response (Figure 8B). The responses
of CRF and DOI after CRF were still signiﬁcant in the presence
of H-89 [F(1,5) = 6.34, p < 0.05, n = 6]. Thus antagonism of
PKA activity does not aﬀect the CRF/DOI responses. Next we
applied bisindolylmaleimide-I (BIS; 100 nM), a PKC antagonist
to the slices before the application of CRF and DOI following
CRF. We found that BIS blocked the eﬀects of CRF and DOI
following CRF (Figure 9A; n = 6). In the next step we applied
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FIGURE 6 | (A) HEK293 cells transiently transfected with YFP-SAP97 and
either FLAG-5-HT2AR or HA-CRFR1. Cells were treated with control or
CRFR1-CT tat-tagged peptides. YFP-SAP97 co-immunoprecipitation with either
FLAG-5-HT2AR or HA-CRFR1 is significantly inhibited following CRFR1-CT
treatment. (B) Quantitative densitometric analysis of co-immunoprecipitated
YFP-SAP97 western blots, ∗p < 0.05.
FIGURE 7 | Tat-CRFR1-CT peptide abolished the activity of DOI but not
CRF. Representative traces (A) of Layer II (top panel) and Layer III (bottom
panel) shows that after the incubation of slices with Tat-CRFR1-CT peptide
peptide CRF was able to show its usual effects but DOI even applied after
CRF failed to show its effect. (B) Incubation of slices in scrambled peptide did
not prevent the interaction of CRFR1 and 5-HT2A/CRs.
PMA alone, an activator of PKC to the see if it could mimic the
eﬀects of CRF.We observed that PMA (100 nM) produced eﬀects
like CRF. However, DOI applied after PMA failed to produce a
further change in the PC activity (Figure 9B; n = 6).
Single Cell Activity Correlates to VSDI
In order to understand how CRF/DOI may aﬀect the activity of
individual cells we conducted whole-cell patch clamp recordings
in the Layers II and III of PC. To examine the responses in
the Layer II we stimulated LOT using 80 Hz trains which
were identical to stimuli used for VSD imaging. The response
to this train was reduced by CRF (Figure 10A) even though
each stimulus generated an action potential during the train
(not shown). Thus CRF does not seem to have any eﬀect on
the eﬃcacy of the stimulus only the response to them. The
addition of DOI after CRF further reduced the eﬃcacy of these
stimuli. In Figure 10B we show a raster plot of 18 recordings
done from pyramidal cells showing that both CRF and DOI
reduced the activity induced by LOT stimulation (n = 10). Like
that observed in the VSDI recordings the eﬀects of CRF were
reversible after about 15–20 min of washing (Figure 10C), but
we saw no reversibility within the same time frame for DOI
after CRF applications. Finally, we also found that CRF and DOI
reduced the excitability of pyramidal cells as equivalent current
pulses were unable to generate same activity during a 500 ms
pulse of current (Figure 10D). In control recordings at two times
the threshold current required to induce an action potential (I2t)
the average interspike frequency of the train was 44.8 ± 1.1 Hz
while in CRF and DOI this was 39.0 ± 2.0 Hz (p < 0.01) and
42.9 ± 1.3 Hz respectively (p > 0.05 compared to control).
Thus the average frequency of trains generated was not largely
changed. However, the number of action potentials generated by
this current injection was greatly reduced (Control 11 ± 1, CRF
6 ± 1, and DOI 2 ± 1 p’s < 0.001 for all comparisons). Thus the
pyramidal cells generated action potentials at similar or slightly
reduced frequencies but the cells accommodated to the stimulus
generating fewer action potentials.
Corticotropin-releasing factor had variable and highly
complex eﬀects on the excitability of cells located in Layer
III which are almost exclusively GABAergic interneurons.
In contrast to pyramidal cells DOI had no eﬀect on any
recordings done in this cell layer. We have previously shown that
interneurons in Layer III ﬁre with ﬁve well-deﬁned and diﬀering
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FIGURE 8 | Activation of adenylate cyclse abolished CRF/DOI activity
while antagonism of PKA has no effect. In (A) we show the
quantification of the effects of adenylcyclase activation which blocked the
effects of CRF/DOI in the Layers II, III, and DEn. (B) Shows that the
inhibition PKA by H-89 (a PKA antagonist) has no effect on the CRF/DOI
responses in all regions. ∗CRF effect is significantly different compared to
control. # DOI following CRF effect is significantly different from CRF
∗#p < 0.05.
FIGURE 9 | Corticotrophin-releasing factor receptor 1 activity is
mediated through PKC activation. Application of BIS, a PKC antagonist
prevented the effects of CRF and DOI following CRF. In (A) we show
quantitation of PKC antagonism in the presence of CRF and DOI over the range
of stimulation frequencies used to activate the circuit. Application of PMA, a
PKC agonist alone mimicked the CRF effects. However, application of DOI
following PMA failed to produce further change in the circuit activity. In (B) we
show quantitation of PKC agonism in the presence of both CRF and DOI over
the range of frequencies used to activate the circuit. ∗p < 0.05. PMA effect is
significantly different compared to control.
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FIGURE 10 | Patch clamp recordings from Layer II pyramidal cells
show that CRF and DOI reduced action potential firing. In (A) a
current clamp recording from a pyramidal cell we show that CRF and
subsequently DOI attenuated the excitation produced by a 1 s 80 Hz
pulse. In (B) a raster plot of 18 recordings from Layer II cells shows a
summary of these data. In (C) like in the VSD recordings the effects of
CRF were slowly reversible. In (D) a current clamp recording from a
typical pyramidal cell shows that the number of action potentials
produced by current injection over a range of current steps was reduced
by CRF and DOI. This effect was primarily due to increased
accommodation with no prominent change in firing frequency (see text for
a more complete description).
spike patterns (Gavrilovici et al., 2012). The naming of these
ﬁring patterns were adopted from the nomenclature deﬁned in
Ascoli et al. (2008). Here we found that CRF altered the spiking
patterns of some, but not all these subtypes. There were two types
of outcomes on these interneurons. One response converted
low frequency ﬁring patterns to high frequency ones. While
the second type of response showed a conversion from a high
frequency spiking patterns to low. In some recordings there was
no apparent eﬀect of CRF. In Figure 11A we show an example
of the conversion of an ALF interneuron (<50 Hz average ﬁring
frequency at two times threshold (I2t); also see methods for
description of classiﬁcations) to an AHF phenotype (>50 Hz at
I2t). All interneurons having this initial phenotype responded in
this manner (Control: 44.0 ± 0.1; CRF: 62.3 ± 0.6 Hz, p < 0.001,
n = 14). The graph in Figure 11B shows the averaged interspike
frequency versus spike interval relationship for all 14 recordings.
One line shows the relationship at the threshold (It) where a train
of action potentials is elicited, while the other shows the relation
at I2t. It is evident that CRF produced a dramatic change in the
input/output responses of these cells. Similarly those cells that
had the weakly ALF phenotype (wALF) all converted to an AHF
pattern (Figure 11C; Control: 29.1 0 ± 0.6; CRF: 69.1 ± 0.8 Hz,
p< 0.001, n= 6). The average change in the input/output for this
population is shown in Figure 11D. The second type of responses
were more variable. Interneurons that initially ﬁred with an AHF
phenotype sometimes converted to ALF pattern (Figures 12A,B;
Control: 62.9 ± 0.9; CRF: 43.9 ± 1.0 Hz, p < 0.001, n = 6) but
another cohort did not change (n = 7; not shown). NAvHF
interneurons (>100 Hz) similarly had variable responses; some
did not change (n = 4) while another group converted to the
weakly adapting low frequency interneuron phenotype (wALF;
Figures 12C,D, Control: 101.3 ± 1.0; CRF: 28.1 ± 0.9 Hz,
p< 0.001, n = 5). The ﬁfth pattern that we identiﬁed (Gavrilovici
et al., 2012), strongly ALF, which occurred in less than 5%
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FIGURE 11 | A subpopulation of interneurons from Layer III increased
their firing frequency after the application of CRF. In (A) we show an
example of ALF interneuron that converted to AHF firing pattern after the
application of CRF. The graphs in (B) show the average of firing frequency
against interspike interval number from 14 ALF at one times threshold and two
times threshold (It and I2t respectively). (C) Shows an example of a wALF
(weakly adapting low frequency) interneuron that converted to AHF type after
the application of CRF. A plot of the average of firing frequency against
interspike interval number from the five ALF interneurons that converted to AHF
after the application of CRF is shown in (D).
of the 205 recordings, was not seen in 38 recordings we did
here and so we are unsure as to the eﬀects of CRF on these
cells.
Discussion
Disturbances in homeostasis due to stressors are thought to
mitigate the onset of depression or anxiety (de Kloet et al.,
2005). The physiological mechanisms following stressful stimuli
involve various brain regions, such as amygdala, hippocampus
and nucleus accumbens. These areas interact and integrate their
responses by releasing neuromodulators that regulate stressor
reactions (Mora et al., 2012). The importance of these brain
regions during stress and anxiety has been extensively studied
(McEwen, 2007). The PC, a part of the limbic region that
is interconnected with amygdale, hippocampus, and prefrontal
cortex (Loscher and Ebert, 1996), has not been extensively
studied to determine how it may respond to stressors. Odor
perception can induce stressor responses which are highly
context dependent (Kadohisa, 2013; Krusemark et al., 2013)
and therefore it is reasonable to hypothesize the PC could be
modulated by neurochemical processes depending on the nature
of the stressor. In this context, we have shown here that CRF
and 5-HT receptors, which are implicated in stress, anxiety and
depression in many regions (Aghajanian and Davis, 1975; Kahn
et al., 1988; Eison, 1990; Davis, 1992; Arborelius et al., 1999;
Naughton et al., 2000; Muller et al., 2003; Merali et al., 2004;
Risbrough and Stein, 2006) have profound eﬀects in the PC.
What is surprising is that although CRF and 5-HT2R activation
is known to be anxiogenic, they dampened the overall activity
of the PC. Thus deactivation of PC would seem to be the usual
response to these ligands in this particular brain region. As the
primary function of the PC is olfaction this may in fact be
a reﬂexive response to dampen output to the amygdala from
the PC which is presumably already being, through prefrontal
or other pathways, activated by the perceived threat. Our data
also indicate that serotonergic neurotransmission on 5-HT2R
receptors, in the stimulation paradigm used here, when CRF
is released (presumably from the central amygdala or local
CRF containing neurons). Thus, it would seem that amygdala
activation is required for this CRF/DOI interaction to occur.
The eﬀects of DOI were dependent on prior CRFR1 activation
requiring the formation – CRFR1 – 5-HT2R complex. However,
the interaction of CRFR1 and 5-HT2A/CRs appears to only
occur on pyramidal cells as the interneurons of Layer III were
unaﬀected by DOI application. As pyramidal cells express both
5-HT2A/CRs we are unsure what subtype(s) are being traﬃcked.
Although the application of PMA mimicked CRF, activation of
PKC did not induce DOI responses (like CRF). This outcome
ﬁts with the interpretation that the DOI activity is dependent
on CRFR1 activation and presumably CRFR1 endocytosis. So
although PKC activation dampened excitability, DOI could not
add to this eﬀect as CRFR1 activation had been bypassed.
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FIGURE 12 | Another subpopulation of interneurons from Layer III
reduced their firing frequency after the application of CRF. In (A) an
example of AHF interneuron that converted to ALF phenotype after the
application of CRF is shown. The plots in (B) show how the average firing
frequency versus interspike interval number was changed in the six interneurons
where this occurred at one times threshold and two times threshold (It and I2t
respectively). Similarly in (C) we show an example of a NAvHF interneuron that
converted to the wALF phentotype after CRF application. (D) Shows the
quantification of the firing frequency against interspike interval number for five
NAvHF interneurons.
Corticotropin-releasing factor activity seems to vary with
brain region and cell type. Another study using VSDI
demonstrated that CRF enhanced hippocampal excitation (von
et al., 2011) and several patch clamp studies reported that CRF
was able to facilitate action potential ﬁring in hippocampus
(Aldenhoﬀ et al., 1983; Hollrigel et al., 1998; Blank et al.,
2003). CRF has also been shown to depress excitatory
neurotransmission in the hippocampal formation (Sheng et al.,
2008), but we found no evidence of this here as LOT stimulation
was unaﬀected by CRF. It has also been shown that in the
prefrontal cortex CRF decreased the excitability of pyramidal cells
by enhancing GABA release (Tan et al., 2004). Although we did
not measure GABA release here, this outcome seems unlikely.
The NAvHF interneurons whose excitability was reduced densely
innervates Layer II pyramidal cells and therefore a reduction
GABA release would be predicted. The reason for these highly
variable outcomes throughout the brain is unclear. However,
these outcomes cannot be explained by CRF interacting with
diﬀering CRFRs. It is more likely that divergent actions of CRF
are, at least, in part due to divergent signaling pathways as
other studies have shown that CRFR1 can activate either Gαs or
Gαq/11 signaling. Elliot-Hunt and co-workers reported that CRF
activated PKA and MAPK signaling pathways in hippocampus
(Elliott-Hunt et al., 2002). In another study, Sheng et al. (2008)
observed, in cultured hippocampal neurons, inhibition of PKC
abolished CRF regulation of NMDA currents. (Tan et al., 2004)
showed that forskolin did not mimic the actions of CRF but
PKC activation did; observations that are identical to ours. Thus
it seems that CRF signally is promiscuous varying from cell to
cell and region to region. Interestingly we found that activation
of adenylcyclase by forskolin- occluded the eﬀects of CRF. The
mechanism by which this occurs is unclear but may involve
heterologous desensitization of the CRFR1 itself as a consequence
of forskolin mediated activation of PKA. As we have found no
evidence CRF signals through diﬀering cascades here (although
it cannot be ruled out), it seems more likely that the CRFR1
activation is linked to divergent eﬀector cascades that alter
neuron function.
The most profound eﬀect of the CRFR1/5-HT2A/CR
interaction is the dampening of the Layer II excitability.
These likely accounts for the reduced activation the circuit with
the highly variable eﬀects of CRF on interneurons in Layer
III modulating the overall response. Although, it would also
seem reasonable to conclude that the reduced excitability of the
majority of interneurons would also enhance the dampening
of circuit activation. Nevertheless, the fact that the activity
of CRF in Layer III varied changing from one functionally
distinct interneuron subtype to another argues for more subtle
modulatory roles for CRF within this circuit. Given that
an important function of interneurons is to control network
synchrony this suggests that CRF in Layer III modulates the ﬁring
patterns of the PC and may also be important for governing the
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impact of circuit activation. This variability in CRF
eﬀects has been observed before; when administered
intracerebroventricularly it produced both inhibitory and
excitatory eﬀects on dorsal raphae nucleus neuron ﬁring rate.
Both eﬀects were mediated through CRFR1 as antalarmin
attenuated CRF’s activity (Kirby et al., 2000). So in sum our
data suggest that the most salient outcome of CRF/DOI activity
is to reduce the Layer II activity which then attenuates the
disinhibition.
5-HTR activation also has been shown elsewhere to produce
heterogeneous eﬀects in many brain regions. Here, we show
DOI reduced PC pyramidal cell activity but had no eﬀect on
the interneurons in Layer III. By contrast activation of 5-HT1CR
(subsequently renamed 5-HT2CR) receptors in PC produced
increased pyramidal cell activity (Sheldon and Aghajanian, 1990).
In same study activation of 5-HT2Rs in PC increased the
occurrence of spontaneous inhibitory post-synaptic potentials
(IPSP’s) on pyramidal cells. This was shown to be due to increased
ﬁring of interneurons located in the border between Layers
II and III. Initially which subtype of 5-HT2R was activated
was not known as the 5-HT was used as the agonist and a
non-selective 5-HT2R antagonist was used to block this eﬀect.
Later it was shown that this eﬀect was mediated by the 5-
HT2AR and not 5-HT2CR (Marek and Aghajanian, 1994). We
found that activation of the 5-HT2A/CRs on pyramidal cells
decreased excitability although this required previous CRFR1
activation. This argues that the eﬀects are mediated by 5-
HT2A/CRs, consistent with the ﬁndings of Magalhaes et al.
(2010). We also found that DOI had no eﬀect on interneuron
spiking patterns. These results are surprising as 5-HT2A/CRs
are expressed in this layer and one might expect activation
to alter the activity of cells in this layer. Therefore it would
seem that the increased interneuron activity observed by
Aghajanian and coworkers is not due to changes in their intrinsic
excitability and likely represents increased excitatory drive onto
these interneurons or alteration in the neurotransmitter release
mechanisms.
In summary, this study shows how neuronal activity through
PC layers is altered by the activation of CRFR1 and 5-HT2A/CRs.
To emphasize it is surprising that two neurotransmitters that
heighten anxiety would reduce excitability in a circuit which has
strong connections to hippocampus, amygdala and prefrontal
cortex. This may represent a behavioral feedback mechanism
to blunt odor induced stressor responses. What is also striking
is the highly complex and varied nature of the CRFR1 eﬀects
on the diﬀering cell populations. The use of the selective Tat-
CRFR1-CT peptide indicates these eﬀects of DOI are mediated
through an interaction between CRFR1/5-HT2A/CRs with one or
multiple PDZ domain-containing proteins (like SAP97), but it
doesnot rule out other similar interactions may occur with other
receptor subtypes. Finally, it seems CRFR1 may signal through
diﬀering G protein signaling cascades and so it may be possible
under diﬀering conditions, epilepsy, chronic stress or perhaps
head injury, that these pathways may be plastic and modulation
of this network and others may be dynamic.
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